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Lymphedema-distichiasis (LD) is an autosomal dominant disorder that classically presents as lymphedema of the limbs,
with variable age at onset, and double rows of eyelashes (distichiasis). Other complicationsmay include cardiac defects,
cleft palate, extradural cysts, and photophobia, suggesting a defect in a gene with pleiotrophic effects acting during
development. We previously reported neonatal lymphedema, similar to that in Turner syndrome, associated with a
t(Y;16)(q12;q24.3) translocation. A candidate gene was not found on the Y chromosome, and we directed our efforts
toward the chromosome 16 breakpoint. Subsequently, a gene for LD was mapped, by linkage studies, to a 16-cM
region at 16q24.3. By FISH, we determined that the translocation breakpoint was within this critical region and
further narrowed the breakpoint to a 20-kb interval. Because the translocation did not appear to interrupt a gene,
we considered candidate genes in the immediate region that might be inactivated by position effect. In two additional
unrelated families with LD, we identified inactivating mutations—a nonsense mutation and a frameshift mutation—in
the FOXC2 (MFH-1) gene. FOXC2 is a member of the forkhead/winged-helix family of transcription factors, whose
members are involved in diverse developmental pathways. FOXC2 knockout mice display cardiovascular, craniofacial,
and vertebral abnormalities similar to those seen in LD syndrome. Our findings show that FOXC2 haploinsufficiency
results in LD. FOXC2 represents the second known gene to result in hereditary lymphedema, and LD is only the
second hereditary disorder known to be caused by a mutation in a forkhead-family gene.
Introduction
Lymphedema is a common chronic, debilitating condi-
tion that affects millions of people worldwide. It is usu-
ally secondary to filariasis, surgery, trauma, or infec-
tion. Genetic causes of lymphedema have been of much
interest, partly due to the possibility of identification of
molecular insights into diagnosis, prevention, or treat-
ment. Congenital lymphedema can be found associated
with Noonan and Turner syndromes. Hereditary lym-
phedema is heterogeneous and usually occurs as an au-
tosomal dominant trait. The most common form of con-
genital, primary hereditary lymphedema—Milroy dis-
ease (MIM 153100)—is sometimes caused by mutations
in the vascular endothelial growth–factor receptor-3
gene (VEGFR-3, or FLT4) (Karkkainen et al. 2000).
Other forms of hereditary lymphedema include lym-
phedema-distichiasis syndrome (LD [MIM 153400]) in
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which lymphedema, primarily of the limbs, with variable
age at onset, is seen together with distichiasis, or double
rows of eyelashes. The extra eyelashes grow from the
Meibomian glands and may protrude into the cornea,
producing severe corneal abrasions. This combination
was first described by Neel and Schull (1954, pp. 50–51)
and by Falls and Kertesz (1964). A number of subse-
quent case reports have shown additional complications
in some families, including extradural cysts, cardiac de-
fects, and cleft palate (Falls and Kertesz 1964; Robinow
et al. 1970; Schwartz et al. 1980; Corbett et al. 1982;
Goldstein et al. 1985). This constellation of defects sug-
gests that the gene involved would likely have pleio-
trophic effects during development.
We previously reported neonatal lymphedema similar
to that seen in Turner syndrome associated with a Y;16
translocation (Erickson et al. 1995). We searched for
an “anti-Turner” gene, which might be involved in lym-
phedema on the Y-chromosome side of the translocation
(Schmidt Drury et al. 1998). However, we were not able
to find a candidate gene on this portion of the Y chro-
mosome and turned our attention to the der(16) break-
point region at 16q24.3. Shortly thereafter, LD was
mapped to a 16-cM region on distal chromosome 16
(Mangion et al. 1999). We determined that the break-
point was within this region and narrowed the break-
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point to a small, 20-kb segment. By analysis of neigh-
boring genes, we identified inactivating mutations in the
FOXC2 forkhead/winged-helix transcription factor in
two families with autosomal dominant LD. We specu-
late that the lymphedema phenotype associated with the
translocation breakpoint is due to position effect. These
results show that mutations in the FOXC2 gene are
responsible for LD.
Subjects and Methods
Subjects
The proband with the t(Y;16) translocation was as-
certained at the Department of Pediatrics at the Uni-
versity of Arizona and has been described elsewhere
(Erickson et al. 1995). Family 1 (fig. 3) was ascertained
at the Greenwood Genetic Center, in Greenwood, SC.
Family 2 (fig. 3) was originally seen at the Pediatric
Genetics Clinic at the University of Michigan. Informed
consent for both participation and collection of tissue
samples was obtained from all family members, in ac-
cordance with the procedures of the institutional review
boards of either the University of Michigan Medical
School or the University of Arizona.
FISH
FISH was performed on metaphase spreads from an
Epstein-Barr virus–transformed lymphoblastoid cell
line that was established from the patient with the
t(Y;16)(q11.2;q24;3) translocation, according to stan-
dard procedures. As described elsewhere (Dagenais et al.
1999), metaphase-chromosome slides were denatured
and then hybridized overnight with biotin (biotin-14-
dATP)-labeled probes. A BioNick Translation Kit (Gibco
BRL) was used to label probes from YAC and bacterial
artificial chromosome (BAC) clones and subclones of
PCR products from BAC clone 58A18. Prior to hybrid-
ization, probes were denatured for 8 min at 70C and
were preannealed for 30–60 min at 37C with human
COT-1 DNA (Gibco BRL). FISH signals were visualized
by incubation with two layers of FITC-conjugated avi-
din-DCS (Vector Laboratories) and fluorescin-conju-
gated anti-avidin IgG, whereas chromosomeswere coun-
terstained with 4′,6-diamidino-2-phenylindole (Vector
Laboratories). FISH results were analyzed with a Zeiss
Axioscop epifluorescence microscope and were docu-
mented with a Photometrics SenSys camera and Vysis
Quips imaging software (Applied Imaging). The PCR
primers used for generating the FISH probes were as
follows: PCR 58-1a, 5′-CATTCATTAGTCCATCCATC-
CGTC-3′; PCR 58-1b, 5′-AGAACTATGTTAGCCAGG-
GTA-3′; PCR 58-2a, 5′-GCAGGAAGAAGAAGCACA-
GTCC-3′; PCR 58-2b, 5′-TGTATTTTTTAGCGGAGA-
CGGG-3′; PCR 58-3a, 5′-TAGAGGAGATGGGGAAG-
GGTAGC-3′; PCR 58-3b, 5′-TGATAGGCAGGTAAGC-
AGAGTTCG-3′; PCR 58-4a, 5′-CCCTAAGTTCCAGT-
GCAAGTATCC-3′; PCR 58-4b, 5′-ATGTGACCTGGA-
GCAAGTGACTAAC-3′; PCR 58-5a, 5′-GGGATAGCT-
AAGAAGAAAGCATGT-3′; PCR 58-5b, 5′-CAGATAG-
TTTCTGAAACCTCCGTT-3′; PCR 58-6a, 5′-GACAG-
GCTCCTCCACACAGAG-3′; PCR 58-6b, 5′-GCTGTC-
TTGAGAGGTTGAGATGC-3′; PCR 58-7a, 5′-AATAC-
CTGTTTCTCAAGGACCCG-3′; PCR 58-7b, 5′-TGTG-
TGTGTGTGTGTGTGTGTTCG-3′; PCR 58-8a, 5′-CA-
TGAGTAGTCTTGCATCTCTCTC-3′; PCR 58-8b, 5′-
GACCTAACAGTAGTCAGGAACGCAC-3′; PCR 58-
9a, 5′-AGAGATGGAGTTTCACCGTATTGG-3′; PCR
58-9b, 5′-CCGCACCCACTCGCCCCACAGAGCAC-3′;
PCR 58-10a, 5′-GGTGCTCTGTGGGGCGAGTGGGT-
GCG-3′; PCR 58-10b, 5′-ATCCCAACAGAAGACCT-
TTCCGC-3′.
DNA Sequencing
To amplify the single coding exon of FOXC2, genomic
DNA isolated from peripheral blood or cultured fibro-
blasts of probands and family members was used as tem-
plate in PCR reactions. We used the GC Rich System
(Roche) and primers 5′-TCTCTCGCGCTCTCTCGCTC-
3 and 5′-CTTTTTTGCGTCTCTGCAGCCC-3′ to gen-
erate the PCR products. Before sequencing, PCRproducts
were purified by treatmentwith Exonuclease I (Amersham
Pharmacia Biotech and shrimp alkaline phosphatase
(Amersham Pharmacia Biotech) for 15 min at 37C. En-
zymes were heat inactivated by incubating the reaction at
80C for 15 min. Sequencing was performed by the Se-
quencing Core Laboratory at the University of Michigan,
by the dideoxy termination method and an ABI 377 au-
tomated sequencer. Results were verified by sequencing
both the sense and the antisense strands.
Restriction-Enzyme Analysis
Sequence analysis of the proband in family 1 revealed
the TACrTAGmutation creating a novelBfaI restriction
site. This site was used to confirm the presence of the
mutation in all additional affected family members. A
439-bp region of the FOXC2 gene was PCR amplified
from genomic DNA, by means of the GC-rich protocol
described by Baskaran et al. (1996), with primers 5′-
TCTCTCGCGCTCTCTCGCTC-3′ and 5′-TGCCAGC-
CCTGCTTGTTCTCC-3′. PCR products were column
purified (Qiagen) and were digested withBfaI (NewEng-
land Biolabs) at 37C for 1 h prior to gel electrophoresis.
In family 2, the 4-nucleotide insertion creates a novel
NaeI site. A region surrounding the insertion was PCR
amplified using primers 5′-CGAGCGATGAGCCTG-
TACACC-3′ and 5′-GCGAGGTTGAGAGCGCTCAG-
G-3′. PCR products were purified and digestedwithNaeI
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Figure 1 Results of FISH. BAC clone 58A18 (green), whichmaps
to 16q24.3, crosses the t(Y;16)(q11.2;q24.3) translocation breakpoint
and hybridizes to the der(Y), der(16), and normal chromosome 16.
Metaphase spreads of lymphoblastoid cells from the patient with the
t(Y;16) translocation were hybridized with a biotin-labeled BAC
58A18 probe, as described in the Subjects and Methods section.
at 37C for 2 h, and fragments were resolved by gel
electrophoresis on a 4% agarose gel.
Results
The region of the Y-chromosome translocation break-
point in our patient with congenital lymphedema and a
t(Y;16)(q11.2;q24.3) translocation contained low-level
chromosome Y–specific repeats, making its exact local-
ization by FISH—and, hence, isolation of sequences for
“hopping” to the chromosome 16 side of the break-
point—problematic. We thus obtained a number of YAC
clones from the 16q24.3 region, to identify this break-
point. By FISH, YAC 733F10 was found to cross the
translocation breakpoint. This YACmaps within the 16-
cM interval reported, by Mangion et al. (1999), to con-
tain a gene for hereditary LD. YAC 733F10 contains
marker WI-15115, which was used to identify BAC
463O9, which, in turn, was used to identify BAC 58A18
from the GenBank databases (GenBankOverview). BAC
clone 58A18 crossed the translocation breakpoint by
FISH (fig. 1). By assembling the previously unassembled
sequence of BAC 58A18, we developed PCR-generated
probes for FISH and narrowed the breakpoint to a 20-
kb interval. The closest candidates were expressed se-
quence tag (EST) AW138879, located 42 kb distally, and
EST AW182066, located 40 kb proximally, neither of
which contained open reading frames. We did not detect
expression of these ESTs by RT-PCR in multiple tissues,
including fibroblasts, lymphoblastoid cells, and a num-
ber of cancer cell lines. Expression was also not detected
in endothelial, lymph node (Clontech), or heart (Clon-
tech) cDNA libraries or by hybridization with EST-spe-
cific probes to the Clontech multiple-tissue array, which
contains RNA from 76 different tissues.
Further database searches of available sequences from
BAC 58A18 and overlapping proximal BAC 463O9 re-
vealed the presence of the FOXF1 (FREAC-1, or FKHL-
5) forkhead-family-member gene, ∼200 kb proximal to
the translocation breakpoint. Although this gene seemed
to be a good candidate for LD, the distance from the
breakpoint was quite large. However, further analysis of
sequences from BAC 463O9 showed the presence of two
additional forkheadlike-family-member genes—FOXC2
and the human orthologue of mouse FKH-6 (FREAC-
7). FOXC2 and FREAC-7 (now termed “FOXL1”
[Kaestner et al. 2000]) had previously been shown to
map to 16q24 in humans and to be tightly linked in both
mouse and humans (Kaestner et al. 1996).Wedetermined
that the two genes map ∼60 kb distal to FOXF1 and
∼120 kb proximal to the translocation breakpoint that
we studied (fig. 2). Thus, three forkhead-family homo-
logues cluster within a 65-kb interval at 16q24.3. The
complete coding sequence (GenBank accession number
AF315075 [GenBank Overview]) of FOXL1 was deter-
mined on the basis of the genomic sequence. We first
investigated FOXC2 for involvement in LD, because of
both its role in heart, craniofacial, and vertebral devel-
opment in the mouse and the fact that it is strongly ex-
pressed in developing mouse blood vessels (Kaestner et
al. 1996; Iida et al. 1997).
The FOXC2 gene produces a 2.2-kb transcript with a
1.5-kb single exon coding region that is highly (∼70%)
GC rich (Miura et al. 1997). Primers were developed for
sequencing the gene from PCR-amplified genomic DNA.
We first sequencedDNA from a fibroblast line established
from a fetus (II-7 in family 1; see fig. 3) that, because of
hydrops fetalis, was electively aborted at 17wk gestation.
The fetal karyotype was 46,XX. The father was diag-
nosed with hereditary LD, and two sons have distichiasis.
An earlier pregnancy (II-6 in family 1) was electively
aborted because of the presence of hydrops and presumed
Turner syndrome, although subsequent pathological ex-
amination did not show internal abnormalities compat-
ible with Turner syndrome. A karyotype was not per-
formed. The family history suggested to us that the
hydrops fetalis seen in the two fetuses was a result of the
lymphedema gene mutation in this family.
A nonsense mutation was found at nucleotide 297 of
the FOXC2 coding region in fibroblasts from fetus II-
7 in family 1, by both forward and reverse sequencing.
This mutation creates a novel BfaI restriction site and
was verified in additional affected family members, by
sequence analysis and restriction digestion of PCRprod-
Fang et al.: FOXC2 Mutations in Lymphedema-Distichiasis 1385
Figure 2 Map of the 16q24.3 region containing the FOXC2 gene. The positions of several sequence-tagged sites and ESTs are indicated.
The shaded boxes represent three forkhead genes—FOXF1, FOXC2, and FOXL1. The hatched box indicates the position of the translocation
breakpoint identified in the patients with the t(Y;16) translocation and lymphedema. The translocation breakpoint is ∼120 kb distal to the
FOXC2 gene. The positions of YAC 733F10, BAC 463O9, and BAC 58A18 are indicated below the map. The arrowheads indicate the positions
of five PCR-based FISH probes used to fine-map the translocation breakpoint
ucts from genomic DNA (fig. 4a). The mutation was
subsequently confirmed in archival tissue from fetus II-
6, by restriction-digestion analysis of PCR products.
The mutation creates a stop codon that would result in
truncation of the predicted protein at amino acid 99
within the conserved forkhead domain. A second family
diagnosed with LD, in which the additional features of
cystic hygroma, arachnoid cysts, and cleft palate were
seen in the proband, was subsequently analyzed (fig. 3).
A 4-nucleotide (GGCC) duplication at position 1093 of
the coding region was detected by direct sequencing (fig.
4b). The mutation, which would create 98 novel amino
acids before truncating the protein, lies in the carboxy-
terminal region after the forkhead domain. This mu-
tation creates a novel Nae I restriction site, which al-
lowed verification of the mutation in all family members
(fig. 4b). Both mutations would result in haploinsuffi-
ciency of the FOXC2 protein and are consistent with a
frequently seen mechanism for dominantly inherited
disorders with variable phenotype.
Discussion
The forkhead “winged-helix” family of transcription
factors now includes 180 members in various species,
with 17 homologues currently known in humans.
Forkhead proteins bind DNA via a highly conserved
100-amino-acid forkhead motif (Kaestner et al. 1993),
a variant of the helix-turn-helix motif, and were first
identified in the Drosophila gene forkhead (fkh) (Wei-
gel et al. 1989). The forkhead DNA–binding domain is
widely conserved among species, and its developmen-
tal role has been defined by mutations in Drosophila,
mice, and other eukaryotes (Kaufmann and Knochel
1996). The human forkhead genes generally map
throughout the genome, with the exception of 16q24.3,
where three forkhead genes—FOXF1 (FKHL-5, or
FREAC-1), FOXL1 (FREAC-7), and FOXC2 (MFH-
1)—are located. This clustering was previously noted in
both humans and mice, and we have found that these
genes lie within a 65-kb region in humans. FOXC2 and
FOXL1 are tightly linked, suggesting coordinate regu-
lation (Kaestner et al. 1996).
No mutations in FOXC2 have been previously de-
scribed in humans. Mutations in other forkhead-family
genes have been found in association with chromosomal
translocations in acute lymphocytic leukemia (Parry et
al. 1994), secondary acute leukemia (Hillion et al.
1997), and alveolar rhabdomyosarcoma (Galili et al.
1993) but, to date, in only one other hereditary disor-
der. Mutations in the FOXC1 (FKHL-7) gene have
been identified in a number of families with dominantly
inherited glaucoma phenotypes, including Axenfeld
anomaly, Rieger anomaly, iris hypoplasia, and Rieger
syndrome (Nishimura et al. 1998; Lehmann et al. 2000;
Mirzayans et al. 2000).
Mice with targeted disruptions of the FOXC2 gene
have a variety of developmental abnormalities. The gene
is expressed in the developing mesodermal mesenchyme
of the head, kidney, and bones and may play a role in
somite formation. It is also expressed in the developing
heart, blood vessels, and limbs and is essential for nor-
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Figure 3 Pedigrees of families with LD. All living members of
both families were examined clinically, as were the two fetuses in
family 1. The current ages of all relevant family members are indicated
(yo p years old). Family 1 was ascertained via fetus II-7, which was
electively aborted at 17 wk gestation, because of hydrops fetalis. Path-
ological examination showed severe nonimmune hydrops. No heart
defects were noted. Additional family members presented with either
lymphedema-distichiasis or distichiasis alone in younger individuals.
Onset of lymphedema in I-1 was at 12 years of age. Fetus II-6 was
electively aborted because of cystic hygroma and hydrops. The pro-
band in family 2 was ascertained at age 4 mo, when he presented with
cleft palate, cystic hygroma, tetralogy of Fallot, and distichiasis. Ad-
ditional family members showed either lymphedema-distichiasis or dis-
tichiasis alone. No other family members had clinical signs of con-
genital heart disease, although echocardiography was not performed.
Age at onset of lymphedema in individual II-2 was the early 30s,
whereas that in individual III-2 was 17 years. Both pedigrees are con-
sistent with an autosomal dominant mode of inheritance.
mal development of the aortic arch and axial skeleton
(Kaestner et al. 1996; Yang et al. 2000). Mice deficient
in FOXC2 die either ∼12.5 d postconception or shortly
after birth and show abnormalities of the heart, aorta,
palate, and vertebrae, abnormalities that are some-
times seen in LD. The most commonly found abnor-
mality was interruption of the aortic arch and ventric-
ular-septal defect, similar to that seen in DiGeorge
syndrome (Iida et al. 1997). No lymphedema has been
reported in FOXC2-deficient mice, and heterozygotes
have been noted either to be normal (Iida et al. 1997)
or to exhibit ocular abnormalities, including abnor-
malities in ocular drainage structures, hypoplastic iris,
and thin iris and pigment epithelium (Smith et al. 2000).
These abnormalities are thought to arise from abnormal
mesodermal development of the iris. The abnormalities
in anterior-chamber drainage of aqueous humor are dis-
tantly related to lymphedema. Detailed examination for
lymphedema and distichiasis in FOXC2-deficient mice
has not been reported but is warranted on the basis of
our findings, as is detailed examination of ocular struc-
tures in patients with LD.
Both mutations seen in the two families described in
the present study would be predicted to truncate and
inactivate one allele of FOXC2 in affected patients. No
mutations were detected in the normal allele, by for-
ward and reverse sequencing of the entire coding region.
The results are consistent with an autosomal dominant
mode of inheritance due to haploinsufficiency. This
mechanism of mutation and mode of inheritance are
known to result in variability in phenotype in a number
of human genetic disorders, especially when found in a
developmental gene with pleiotrophic effects. This is
likely to account for the variable phenotype seen in LD,
which can include cleft palate, extradural cysts, and
heart defects. As we have found in family 1, fetal cystic
hygroma and hydrops can also be associated with
FOXC2mutation and should be considered as a further
phenotypic manifestation.
We hypothesize that the translocation in our index case
inactivates the FOXC2 gene—and, perhaps, other genes
in the region—by a position effect such as has been ob-
served with PAX6 and SOX9 inactivation in humans
(Kleinjan and van Heyningen 1998). SOX9 inactivation
from breakpoints as far as 850 kb away from the gene
has been observed. Interestingly, it has also been shown
that primary congenital glaucoma in one of the patients
described by Nishimura et al. (1998) was caused by in-
activation of FOXC1, as a result of a translocation po-
sition effect. The breakpoint described in the present
study is∼120 kb 3′ of the FOXC2 gene. Since the FOXL1
gene maps between the two, it could also be inactivated
and have phenotypic effects in this patient.Unfortunately,
the patient was lost to long-term follow-up at infancy,
and clinical outcome is unknown. We examined this hy-
pothesis by measuring FOXC2mRNA levels in lympho-
blastoid cells from the translocation patient, compared
with those in normal control cell lines. However, no ex-
pression of FOXC2 was found in these cells by either
northern blot analysis or reverse-transcriptase PCR.
The finding of inactivating mutations in one allele of
FOXC2 in two unrelated families with LD, in con-
junction with a likely position-effect inactivation in a
third individual, provides strong evidence that thesemu-
tations are responsible for the disorder. Hereditary lym-
phedema is a heterogeneous disorder, and mutations in
the FLT4 (VEGFR-3) gene at 5q35 have been shown
to be one cause of hereditary lymphedema type I, or
Milroy disease (Karkkainen et al. 2000). The phenotype
in LD can include not only lymphedema and distichiasis
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Figure 4 Mutation analysis in two families with hereditary lymphedema. Mutations in the FOXC2 gene were detected by direct sequencing
of the PCR-amplified coding region of the gene. Results were confirmed by sequencing the reverse strand and by restriction-enzyme analysis.
a, Sequencing revealed a TACrTAG nonsense mutation (C297G) (arrow, left panel) in the proband (II-7) in family 1, creating a novel BfaI
restriction site. The right panel shows the cosegregation of the novel restriction site with the LD phenotype. Fetus II-6 was also shown to have
the mutation, by restriction digest analysis (not shown). A 439-bp region of the FOXC2 gene was PCR amplified and digested with BfaI.
Products from normal alleles are not cut and remain 439 bp, whereas the mutant allele is cut into 383- and 53-bp fragments (not retained on
gel). b, Sequence analysis revealing a 4-bp insertion in the proband (IV-2) in family 2. The GGCC insertion creates a shifted sequence beginning
at the arrow (left panel). A novel NaeI restriction site is created by the insertion. The right panel shows the cosegregation of the NaeI fragments
with the LD phenotype in family 2. PCR was used to amplify a 125-bp region of the FOXC2 gene (129 bp for the mutant allele).NaeI digestion
of the PCR products results in 35- and 90-bp fragments for normal alleles, because of the presence of a naturally occurring NaeI site in the
product. In alleles with the insertion, the 129-bp product is cut twice, generating two 35-bp fragments and a 59-bp fragment. Bands labeled
“HD” show uncut heteroduplexes.
but also abnormalities of cardiac and skeletal devel-
opment and, perhaps, of other tissues. This is consistent
with the predicted pleiotrophic effects of mutations in
a forkhead gene such as FOXC2, which plays a key role
in multiple developmental processes involving mesen-
chymal cell interactions. The identification of the gene
responsible for LD will make molecular diagnoses pos-
sible and will allow a better definition of both this syn-
drome and its frequency. It also provides further insight
into the mechanisms of primary lymphedema and the
role of FOXC2 and forkhead genes, in general, in hu-
man development and genetic disease.
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